COMMUNIQUÉS West-GlobeNewswire

Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust
14/01/2019
Aleafia Cannabis Complements CannTrust’s Supply for growing Adult-use, Medical Sales TORONTO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia ” or the “ Company ”) [...]
Scilex Announces Addition of ZTlido® to Express Scripts National Formularies
14/01/2019
SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Scilex Pharmaceuticals Inc. (SCILEX), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE), today announced that Express Scripts has added ZTlido ® (lidocaine topical [...]
Scilex Announces ZTlido® Insurance Coverage for ~100 Million Insured Lives(1)
14/01/2019
SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Scilex Pharmaceuticals Inc. (SCILEX), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE), today announced that ZTlido ® (lidocaine topical system) 1.8% (ZTLIDO) is [...]
Ancient Nutrition Names Greg Shearson as CEO, Adding to Leadership Team of Founders Jordan Rubin and Dr. Josh Axe
14/01/2019
Former CEO of Merrick Natural Pet Care Brings 30 Years of Leadership Experience to Leading Natural Health and Wellness Brand NASHVILLE, Tenn., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Ancient Nutrition announced today that [...]
Zomedica Announces $4.28 Million Private Placement Closing and Corporate Update
14/01/2019
ANN ARBOR, Mich., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today announced the [...]
111, Inc. Presented at the 37th Annual J.P. Morgan Healthcare Conference
14/01/2019
SHANGHAI, China, Jan. 14, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that it presented at the 37th Annual J.P. [...]
Digirad Names David Noble as Interim Chief Financial Officer
14/01/2019
SUWANEE, Ga., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD) (“Digirad”) today announced that David Noble, Digirad’s current Chief Operating Officer, will assume the additional role of Interim [...]
Arrayit Corporation Aces Fourth Consecutive Round of Proficiency Testing with a Top Proficiency Testing Company
14/01/2019
Sunnyvale, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, reports that its clinical team has aced four consecutive rounds of proficiency testing ( [...]
Nexstim Plc Depression Therapy Business Update
14/01/2019
Company announcement, Helsinki, 14 January 2019 at 09.00 Nexstim Plc Depression Therapy Business Update Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering [...]
Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance Treatment
14/01/2019
Results from this short clinical pharmacology trial inform and support further clinical development of ensifentrine as an add-on to dual and triple COPD therapy Investment community conference call scheduled for 8 am [...]
MDxHealth (R): MDxHealth Provides Business Update
14/01/2019
NEWS RELEASE REGULATED INFORMATION INSIDE INFORMATION January 14, 2019 - 07:00 CET Preliminary 2018 financial results Total genomic test volumes up 16% Implemented operational cost reduction of ~$10 Million IRVINE, CA, [...]
MDxHealth (R) : MDxHealth dévoile ses résultats de l'exercice 2018
14/01/2019
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES INFORMATIONS PRIVILEGIEES Le 14 janvier 2019 - 07h00 CET Résultat financier provisoire de l'exercice 2018 Augmentation du total des volumes de test génomique de 16 % Mise [...]
ASLAN Pharmaceuticals Announces Study Results from Phase 2 Study of Varlitinib in First-line Gastric Cancer
13/01/2019
SINGAPORE, Jan. 14, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]
UPDATE - Immucor Announces Health Canada Approval for Echo Lumena™; Next Generation, Fully Automated Instrument Powers Smaller to Mid-Volume Labs
11/01/2019
Faster, clearer blood compatibility results now available NORCROSS, Ga., Jan. 11, 2019 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that its next [...]
Sanofi: Availability of the Pre-quarterly Results Communication
11/01/2019
Availability of the Pre-quarterly Results Communication Paris, France - January 11, 2019 - Sanofi announced today that its Pre-Quarterly Results Communication document is available on the "Investors" page of the company [...]
Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »
11/01/2019
Mise en ligne du document «Pre-quarterly Results Communication » Paris - Le 11 janvier 2019 - Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « Pre- [...]
InspireMD Receives Noncompliance Notice from NYSE American
11/01/2019
TEL AVIV, Israel, Jan. 11, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery [...]
Four Stocks Set to Take Advantage of Hemp and Edibles Legalization
11/01/2019
VANCOUVER, British Columbia, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Mugglehead believes this year could be a big one for marijuana edibles. With hemp recently being legalized in the U.S. and Canada expecting to legalize [...]
Easton Announces Status Updates on its $2,600,000 Framing Contract to Construct 150 Homes, Including New Additional Project
11/01/2019
TORONTO, ON, Jan. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Easton Pharmaceuticals Inc. (OTC: EAPH) provides operational update on its $2,600,000 CDN framing contract to build approximately 150 homes just outside [...]

Pages